Indefinite Delivery Contract 75A50122D00014

Award Date 9/15/22
Last Date to Order 9/8/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Clinger Cohen Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a single-award, indefinite delivery/indefinite quantity contract valued up to $100 million to Lovelace Biomedical Research Institute. Under this contract, Lovelace will establish and utilize animal models to support the development of medical countermeasures against radiological and nuclear threats. A $1.986 million cost-plus-fixed-fee delivery order was issued to Lovelace for...
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a single award indefinite delivery contract to Southern Research Institute located in Birmingham, Alabama. With a potential value of $100 million and a period of performance through September 2027, this contract aims to procure biological animal model and medical countermeasure development services in support of the Biomedical Advanced Research and Development Authority. A $4.68...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a single-award, indefinite delivery contract to the Texas Biomedical Research Institute, doing business as the Southwest Foundation for Biomedical Research. The contract has a potential value of $100 million and a period of performance through September 2027 to provide biological animal model and medical countermeasure development support. Two associated delivery orders have been...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) has awarded a single-award, $100 million Indefinite Delivery Contract (IDC) to Mriglobal (dba Midwest Research Institute), a 501(c)(3) not-for-profit research organization. The contract, which has a period of performance through September 2027, is for the development of biological animal models and medical countermeasures. Under this IDC, ASPR can issue task orders for a variety...
The federal contract IDV award provides indefinite delivery of nonclinical biological services to the Department of Health and Human Services (HHS), specifically the Office of the Assistant Secretary for Preparedness and Response (ASPR). The purpose is to establish a network of Good Laboratory Practices (GLP) facilities capable of conducting animal testing and other analytical services to support the development of medical countermeasures against chemical, biological, radiological, and nuclear...
The National Institute of Allergy and Infectious Diseases has awarded an Indefinite Delivery/Indefinite Quantity contract to Sri International to support medical countermeasure development efforts. Task orders issued to date involve animal model development, efficacy testing, and clinical safety studies for monoclonal antibodies, vaccines, and therapeutics against infectious disease targets. Work is conducted at Sri International's facility in West Menlo Park, California over periods ranging...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract valued up to $146,300,000 to Southern Research Institute, a non-profit research organization, to develop and employ animal and animal replacement models of infectious diseases. The contract will support screening, product evaluation, and eventual clinical evaluation of vaccines, therapeutics, and...
The Board of Trustees of the University of Illinois has been awarded a single-award indefinite delivery contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. With a potential value of $100 million and a period of performance through September 2027, this contract provides for animal model development services in support of the Chemical, Radiological, and Nuclear program. A cost-plus-fixed-fee delivery order valued at $2.19 million...
This is a single-award indefinite delivery contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), to Battelle Memorial Institute, a nonprofit research and development organization. The $90 million IDIQ contract, which runs through July 2025, is for the development of animal models and medical countermeasures related to chemical, biological, radiological, and nuclear threats. Under...
This single-award Indefinite Delivery Contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Battelle Memorial Institute, a non-profit organization and manufacturer of goods, to provide pre-clinical models of infectious diseases. The $146.3 million, 7-year contract has a completion date of July 14, 2031 and was awarded on July 15, 2024. The contract aims to develop and employ animal and...
  • 75A50122D00014
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a single-award, indefinite delivery/indefinite quantity contract valued up to $100 million to SRI International of Menlo Park, California. The contract aims to develop animal models for the Biomedical Advanced Research and Development Authority's countermeasure programs against radiological and nuclear threats.

Under the contract, SRI International was issued a $309,727 cost-plus-fixed-fee task order to verify institutional radiation dose responses for acute radiation syndrome animal models including rodents, rabbits, minipigs, and non-human primates at SRI's facility through September 2024. Additionally, the original February 2021 pre-solicitation notice sought proposals from qualified Good Laboratory Practice facilities to establish new or utilize existing animal models to support radiological and nuclear medical countermeasure development through nonclinical laboratory studies over an undefined contract period. Facilities were required to demonstrate appropriate licensure, accreditation, and experience handling select agents and radiation to support efficacy testing under the FDA's "Animal Rule."

Generated 1/19/24, 9:16 AM